The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLS Days features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Dr. Khatereh Ahmadi

Executive Director, Oncology Search and Evaluation Lead - MSD

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Dr. Toni Ahtoniemi

Sr. Manager Client Services - Charles River

14 Sep 08:00 Plenary room Super session 5 – Value creation in service providers

Ms. Anna Aleskog

Country Medical Director, Sweden - Bristol-Myers Squibb

Ms. Benedicte Bakke

Senior Advisor, International Healthcare - DNB

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Mr. Sverre Bengtsson

CEO - Pharma Consulting Group

14 Sep 08:00 Plenary room Super session 5 – Value creation in service providers

Mr. Nils Bohlin

Partner & Global Leader Healthcare - Arthur D. Little

14 Sep 15:15 Exhibition area - NLSDays arena Closing address – Nordic Stars Awards

Dr. Christophe Bonny

CSO - Enterome

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Mr. Carsten Borring

Head of Listings and Capital Market - Nasdaq

14 Sep 14:00 Plenary Room Super session 8 – The Nordic capital landscape

Dr. Søren Bregenholt

Corporate VP and Head of External Innovation - Novo Nordisk

13 Sep 09:30 Plenary Room Super session 1 – Diabetes

Ms. Inga Bruskeland

National Project Coordinator - Research Council of Norway

13 Sep 14:00 Room E Workshop 1 – Eurostars – Funding opportunities for life science SMEs

Dr. Marité Cárdenas Gómez

Head of Research Group - Malmö Högskola

12 Sep 17:00 Exhibition area - NLSDays arena Academic Catwalk

Dr. Anthony T. Cheung

Founder & CEO - enGene

13 Sep 11:15 Plenary Room Super session 2 – Regenerative medicine

Ms. Magda Chlebus

Director of Science Policy - EFPIA

14 Sep 09:30 Room E Workshop 3 – Innovative Medicine Initiative (IMI)

Dr. Stephan Christgau

Partner - Novo Seeds

14 Sep 14:00 Plenary Room Super session 8 – The Nordic capital landscape

Dr. Anna Collén

Project Director Pharmaceutical Development - AstraZeneca

14 Sep 11:15 Room E Workshop 4 – ESS & MAX IV

Dr. Michael Dabrowski

CEO - Pelago Bioscience

14 Sep 08:00 Plenary room Super session 5 – Value creation in service providers

Ms. Anna Danestig

Key Account Manager - PRV

14 Sep 14:00 Plenary Room Super session 8 – The Nordic capital landscape

Dr. Mikael Dolsten

President Worldwide Research and Development and EVP - Pfizer

13 Sep 08:30 Plenary Room Opening plenary

Mr. Olivier Duchamp

Managing Director - NLSDays CEO - Bionordic Services

14 Sep 15:15 Exhibition area - NLSDays arena Closing address – Nordic Stars Awards

13 Sep 08:30 Plenary Room Opening plenary

Dr. Jonas Ekstrand

Director General - SwedenBIO

14 Sep 15:15 Exhibition area - NLSDays arena Closing address – Nordic Stars Awards

13 Sep 08:30 Plenary Room Opening plenary

Mr. Andy Gibbs

Drug Development Leader - Covance

14 Sep 08:00 Plenary room Super session 5 – Value creation in service providers

Mr. Mats Grahn

CEO - Immunovia

13 Sep 15:45 Room E Workshop 2 – Intellectual Property (IP)

Ms. Anna Gran

External Innovation Liaison Nordics - Johnson & Johnson Innovation

12 Sep 18:30 Exhibition area - NLSDays arena Startup Challenge @ NLSDays

Dr. Torkel Gren

Senior Sales Director, Development Services - Recipharm

14 Sep 08:00 Plenary room Super session 5 – Value creation in service providers

Mr. Niels Grønning

Senior Industry Advisor - SAS

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Mr. Niels Grønning

Senior Industry Advisor - SAS

Dr. Sara Gunnerås

Director EU Support Office - SwedenBIO

13 Sep 14:00 Room E Workshop 1 – Eurostars – Funding opportunities for life science SMEs

Mr. Jacob Gunterberg

Partner - HealthCap

13 Sep 15:45 Plenary Room Super session 4 – Financing of phase 3 studies

Dr. Irep Gözen

NCMM Group Leader - University of Oslo

12 Sep 17:00 Exhibition area - NLSDays arena Academic Catwalk

Mr. Peder Hasslev

Managing Director - Saminvest

14 Sep 14:00 Plenary Room Super session 8 – The Nordic capital landscape

Dr. Karin Hehenberger

CEO and Founder - Lyfebulb

13 Sep 09:30 Plenary Room Super session 1 – Diabetes

Dr. Ana Maria Henao Restrepo

Medical Officer, Department of Immunization Vaccines and Biologicals - WHO

13 Sep 14:00 Plenary Room Super session 3 – Response to Outbreaks of Emerging Infectious Diseases

Pr. Poul Henning Jensen

Professor - Dept. Of Biomedicine, Aarhus University

14 Sep 09:30 Room E Workshop 3 – Innovative Medicine Initiative (IMI)

Dr. Christina Herder

Board Member - PCI Biotech AS and Idogen AB

14 Sep 08:00 Plenary room Super session 5 – Value creation in service providers

Dr. Anders Hjelmencrantz

Partner and European Patent Attorney - Zacco

13 Sep 14:00 Plenary Room Super session 3 – Response to Outbreaks of Emerging Infectious Diseases

Ms. Annica Holmberg

Public Affairs Lead - Bristol-Myers Squibb

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Dr. Maj-Britt Kaltoft

BD & L Manager - Statens Serum Institut

12 Sep 17:00 Exhibition area - NLSDays arena Academic Catwalk

Dr. Sven Kili

Head of Cell & Gene Therapy Development - GSK

13 Sep 11:15 Plenary Room Super session 2 – Regenerative medicine

Ms. Pia Kinhult

Strategic Advisor - ESS

12 Sep 10:00 Bus Tour to Lund Medicon Village, Lund / guided tour to MAX IV

Mr. Jonas Klevhag

Business Advisor Digital Media - Innovation Skåne

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Pr. Ralf Knöll

Chief Scientist - AstraZeneca

13 Sep 11:15 Plenary Room Super session 2 – Regenerative medicine

Mr. Olivier Laing

Senior Associate, IP Solicitor - Potter Clarkson

13 Sep 15:45 Room E Workshop 2 – Intellectual Property (IP)

Ms. Marianne Larsson

Innovation Director - Innovation Skåne

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Dr. Jukka Lausmaa

Research manager, Medical technology - RISE

Dr. Peter Lindberg

EUROSTARS Program Manager - Vinnova

13 Sep 14:00 Room E Workshop 1 – Eurostars – Funding opportunities for life science SMEs

Pr. Charlotte Ling

Professor - Lund University

13 Sep 09:30 Plenary Room Super session 1 – Diabetes

Ms. Titi Lundgren

CMO - Coala Life

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Dr. Yilmaz Mahshid

Investment Manager Life Science - Industrifonden

14 Sep 14:00 Plenary Room Super session 8 – The Nordic capital landscape

Pr. Julian Marchesi

Professor - Imperial Collage of London

Dr. Michael May

CEO - Center for Commercialization of Regenerative Medicine

Dr. Elisabet Nielsen

EUREKA National Project Coordinator - Vinnova

13 Sep 14:00 Room E Workshop 1 – Eurostars – Funding opportunities for life science SMEs

Dr. Bjørg Nilsson

Senior Advisor - Norwegian Institute of Public Health

Dr. Gunnstein Norheim

Senior Scientist - Norwegian Institute of Public Health

13 Sep 14:00 Plenary Room Super session 3 – Response to Outbreaks of Emerging Infectious Diseases

Dr. Per Norlèn

CEO -Alligator Bioscience

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Dr. Mathias Norrman

Principle Scientist - Novo Nordisk

Dr. Peter Olofsson

CEO - Redoxis AB

14 Sep 09:30 Room E Workshop 3 – Innovative Medicine Initiative (IMI)

Mr. Pontus Ottosson

Head of Investments - Chalmers Ventures

14 Sep 14:00 Plenary Room Super session 8 – The Nordic capital landscape

Mr. Mattias Paulsson

Partner & CEO - Lytics

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Mr. Olof Pierrou

Managing Director, Investment Banking Division - DNB

13 Sep 15:45 Plenary Room Super session 4 – Financing of phase 3 studies

Ms. Magali Poinot

Advisor and Legal Manager - IMI Joint Undertaking

14 Sep 09:30 Room E Workshop 3 – Innovative Medicine Initiative (IMI)

Dr. Gerard Pöltl

Regional Sales Manager - Charles River Laboratories

Dr. Hanne B. Rasmussen

Vice President - Novo Nordisk

14 Sep 11:15 Room E Workshop 4 – ESS & MAX IV

Dr. Stefan Ries

Global Head of External Innovation, Oncology Discovery - pRED Roche

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Dr. Gunnar Sandberg

Programme Manager, Health Division - Vinnova

14 Sep 09:30 Room E Workshop 3 – Innovative Medicine Initiative (IMI)

Dr. Anna Sandström

Director Science Relations - AstraZeneca

14 Sep 11:15 Room E Workshop 4 – ESS & MAX IV

Mr. Jo Sawyer

Head of External Partnerships - Novartis

13 Sep 15:45 Plenary Room Super session 4 – Financing of phase 3 studies

Mr. Ben van der Schaaf

Principal - Arthur D. Little

13 Sep 15:45 Plenary Room Super session 4 – Financing of phase 3 studies

Dr. Benjamin Schmid

Research Scientist, Disease Models - Bioneer

13 Sep 11:15 Plenary Room Super session 2 – Regenerative medicine

Dr. Gary Sclar

Vice President - Dana-Farber Innovations

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Ms. Ulrica Sehlstedt

Partner - Arthur D. Little

13 Sep 15:45 Plenary Room Super session 4 – Financing of phase 3 studies

Dr. Anthony P. Sigrest

Director, Head of Patient Innovation- AbbVie

14 Sep 09:30 Plenary Room Super session 6 – Digital health

Dr. Steve Smith

European Patent Attorney - Potter Clarkson

13 Sep 15:45 Room E Workshop 2 – Intellectual Property (IP)

Dr. Richard Stratford

CEO - OncoImmunity

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology

Pr. Steffen Thirstrup

Director Regulatory Advisory Board - NDA Reg

13 Sep 11:15 Plenary Room Super session 2 – Regenerative medicine

Dr. Georges Thiry

Acting Director of Vaccine Development - CEPI

13 Sep 14:00 Plenary Room Super session 3 – Response to Outbreaks of Emerging Infectious Diseases

Dr. Birgitte Volck

Vice President, Head of R&D Rare Diseases - GSK

13 Sep 15:45 Plenary Room Super session 4 – Financing of phase 3 studies

Dr. Uli Wendt

Head External Innovation and Alliance Management, Global Diabetes Division, R&D - Sanofi

13 Sep 09:30 Plenary Room Super session 1 – Diabetes

Dr. Henrik Winther

Senior Vice President, Precision Diagnostics - Immunovia

14 Sep 11:15 Plenary Room Super session 7 – Transformative oncology